Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,497 GBX | -0.27% |
|
-0.62% | +3.13% |
16/07 | National Advisory Committee On Immunization Recommends RSV Vaccines, Including Arexvy, For Older Adult Populations | RE |
16/07 | GSK: RSV VACCINATION RECOMMENDED FOR CONSIDERATION BY ADULTS AGE… | RE |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.13% | 7.93TCr | |
+61.53% | 85TCr | |
+36.03% | 63TCr | |
-3.66% | 36TCr | |
+15.06% | 32TCr | |
+9.18% | 30TCr | |
+5.89% | 23TCr | |
+15.84% | 23TCr | |
+15.67% | 18TCr | |
+2.47% | 17TCr |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- Transcript : GlaxoSmithKline plc Presents at 38th Annual J.P Morgan Healthcare Conference, Jan-13-2020 through Jan-16-2020